<p>The Defense Health Agency awarded a $1,299,831.72 definitive contract to Caizio LLC for development of a handheld mechano-optical platelet force sensing device on April 13, 2026, under a total small business set-aside.</p>
<p>Work is performed in Irving, Texas, with an ultimate completion date of August 12, 2028. The contract is priced on a firm fixed price basis.</p>
<p>The Defense Health Agency issued a purchase order to Caizio LLC for $249,586.92 on June 3, 2025, under a Total Small Business set-aside for Phase I Small Business Innovation Research development of a handheld mechano-optical platelet force sensing device. Work is performed in Irving, Texas, with completion targeted for January 2, 2026. The order is priced on a firm fixed-price basis.</p>
The Defense Health Agency awarded a $1,099,586.56 firm fixed price definitive contract to SPZ Technologie LLC for a Phase II Small Business Innovation Research effort under DHA SBIR topic H2-0587 on September 24, 2020, under a total small business set-aside. The contract supports the Military Operational Medicine Research Program (MOMRP) and addresses the SBIR Phase II proposal titled "Human Cell-Based Biosensor (HCB)," originating from SBIR Topic DHA191-006. Work is performed in Los...
<p>The Defense Logistics Agency issued a delivery order to Owens & Minor Distribution Inc. on February 4, 2026, with a ceiling value of $7,684.50 for System Platelet Concentrate PurePRP 30 mL.</p>
<p>Place of performance is Glen Allen, VA. Ultimate completion date is February 5, 2026. The order carries firm fixed-price pricing and was not set aside.</p>
<p>The Defense Department's Medical Supply Chain issued a delivery order to Fisher Scientific Company L.L.C. on March 25, 2026, for a plate analysis application biosystems microplate (96-well format) with a ceiling value of $1,211.62.</p>
<p>Place of performance is Pittsburgh, PA. The order carries a fixed-price structure with economic price adjustment and an ultimate completion date of April 22, 2026. No set-aside was applied.</p>
<p>The Defense Health Agency awarded a purchase order to Biorich Medical, Inc. for $194,030 on March 22, 2025, for platelet-rich plasma kits and high-yield platelet-rich plasma supplies. Performance occurs in Irvine, California. The order carries no set-aside designation and is priced on a firm fixed price basis with a completion date of March 25, 2029.</p>
The Defense Health Agency issued a delivery order to Sysmex America, Inc. on March 14, 2023, with a ceiling value of $2,276,928.81 under the GSA Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) for hematology equipment lease, supplies, and cost-per-test services on a firm fixed-price basis. Place of performance is Bethesda, MD. The order is scheduled for ultimate completion on March 15, 2028. The scope covers hematology analyzer equipment, reagents, supplies, and related...
The Defense Health Agency issued a $142,750.70 delivery order to Siemens Healthcare Diagnostics Inc. on March 2, 2026, under the Critical Analyzers, Laboratory Federal Supply Schedule (FSS-66-III) for in-vitro diagnostic substance manufacturing including APTT, D-dimer, and PT analyzers.
Place of performance is Joint Base Andrews, MD. The order has a ceiling value of $142,750.70 and an ultimate completion date of February 25, 2031. Pricing is firm fixed price with no set-aside applied.
<p>The Defense Logistics Agency, via the Medical Supply Chain, issued a $13,651.65 delivery order to Cardinal Health 200, LLC on November 7, 2023, for platelet collection supplies, with an ultimate completion date of November 30, 2023.</p>
<p>Place of performance is Waukegan, IL. The order is priced on a firm fixed-price basis with no set-aside designation.</p>
<p>The Defense Logistics Agency issued a delivery order to Owens & Minor Distribution Inc. on February 6, 2026, with a ceiling value of $1,781.76 for kit administration platelet client system build transfer display.</p>
<p>Place of performance is Glen Allen, VA. Ultimate completion date is March 2, 2026. The order is issued under firm fixed-price terms with no set-aside applied.</p>